Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer

Biochimie

Volumn 81, Issue 4, 1999, Pages 403-407

  Belfiore, Antonino ^a   Pandini, Giuseppe ^a   Vella, Veronica ^a   Squatrito, Sebastiano ^a   Vigneri, Riccardo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Breast cancer; IGF I hybrid receptors; IGF I receptor; Insulin; Insulin receptor; Insulin like growth factors

Indexed keywords

INSULIN RECEPTOR; SOMATOMEDIN RECEPTOR;

ARTICLE; AUTOPHOSPHORYLATION; CELL GROWTH; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL; THYROID CANCER;

EID: 0032709249     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80088-1     Document Type: Article

References (23)

1. Mazzaferri E.L. Thyroid carcinoma: Papillary and Follicular. Mazzaferri L, Samaan N.A. Endocrine Tumors. 1993;278-333 Blackwell Scientific Publications, Cambridge, MA.
2. Farid N.R., Shi Y., Zou M. Molecular basis of thyroid cancer. Endocrinol. Rev. 15:1994;202-232.
3. Kanamori A., Abe Y., Yajima Y., Manabe Y., Ito K. Epidermal growth factor receptors in plasma membranes of normal and disease human thyroid glands. J. Clin. Endocrinol. Metab. 68:1989;899-903.
4. Haugen D.R.F., Akslen L.A., Varhaug J.E., Lillehaug J.R. Expression of c-erb B-2 protein in papillary thyroid carcinomas. Br. J. Cancer. 63:1992;832-837.
5. Belfiore A., Gangemi P., Costantino A., Russo G., Santonocito G.M., Ippolito O., DiRenzo M.F., Comoglio P.M., Fiumara A., Vigneri R. Low/absent expression of the Met/HGFR identifies papillary thyroid carcinomas with high risk of distant metastases. J. Clin. Endocrinol. Metab. 82:1997;2322-2328.
6. Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55:1995;249-252.
7. Takahashi M.H., Thomas G.A., Williams E.D. Evidence for mutual interdependence of epithelium and stromal lymphoid cells in a subset of papillary carcinomas. Br. J. Cancer. 72:1995;813-817.
8. Arteaga C.L., Kitten L.J., Coronado E.B., Jacobs S., Kull F.C., Allred D.C., Osborne C.K. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J. Clin. Invest. 84:1989;1418-1423.
9. Jonas H.A., Cox A.J., Harrison L.C. Delineation of atypical insulin receptors from classical insulin and type I insulin-like growth factors receptors in human placenta. Biochem. J. 257:1989;101-107.
10. Milazzo G., Yip C.C., Maddux B.A., Vigneri R., Goldfine I.D. High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells. J. Clin. Endocrinol. Metab. 74:1992;1116-1121.
11. Kasuya J., Paz B.I., Maddux B.A., Goldfine I.D., Hefta S.A., Fujita-Yamaguchi Y. Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification. Biochemistry. 32:1993;13531-13536.
12. Soos M.A., Field C.E., Siddle K. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem. J. 290:1993;419-426.
13. Forsayeth J.R., Montemurro A., Maddux B.A., DePirro R., Goldfine I.D. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperatively, and down-regulation. J. Biol. Chem. 262:1987;4134-4140.
14. Ganderton R.H., Stanley K.K., Field C.E., Coghlan M.P., Soos M.A., Siddle K. A monoclonal anti-peptide antibody reacting with the insulin receptor β-subunit. Biochem. J. 288:1992;195-205.
15. Soos M.A., Siddle K., Baron M.D., Heward J.M., Luzio J.P., Bellatin J., Lennox E.S. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem. J. 235:1986;199-208.
16. Kull F.C., Jacobs S., Su Y.F., Svoboda M.E., Van Wyk J.J., Cuatrecoses P. Molecular antibody to receptor for insulin and Somatomedin C. J. Biol. Chem. 258:1983;6561-6566.
17. Gustafson T.A., Rutter W.J. The cysteine-rich domains of the insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. J. Biol. Chem. 265:1990;18663-18667.
18. Soos M.A., Catherine E.F., Lammers R., Ullrich A., Zhang B., Roth R.A., Andersen A.S., Kjeldsen T., Siddle K. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. J. Biol. Chem. 267:1992;12955-12963.
19. Chig-Ju H., James M.H. Gonadotropins and estradiol stimulate immunoreactive insulin-like growth factor-I production by porcine granulosa cell in vitro. Endocrinology. 120:1987;198-207.
20. Neuenschwander S., Robert C.T. Jr., Leroith D. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology. 136:1995;4298-4303.
21. Papa V., Pezzino V., Costantino A., Belfiore A., Giuffrida D., Frittitta L., Vannelli G.B., Brand R., Goldfine I.D., Vigneri R. Elevated insulin receptor content in human breast cancer. J. Clin. Invest. 86:1990;1503-1510.
22. Milazzo G., Giorgino F., Damante G., Sung C., Stampfer M.R., Vigneri R., Goldfine I.D., Belfiore A. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res. 52:1992;3924-3930.
23. Frattali A.L., Pessin J.E. Relationship between α subunit ligand occupancy and β subunit autophosphorylation in insulin/insulin like growth factor-1 hybrid receptors. J. Biol. Chem. 268:1993;7393-7400.